PROM1 and androgen insensitivity syndrome: Third, chronic treatment with ACEIs does not increase the number of circulating stem cells (CD133+) and early EPCs (CD133+/VEGFR2+) in AIS, and in fact, it is an independent factor associated with lower numbers of these cells on day 7 after AIS.